Inflammatory Bowel disease with Hepatitis virus infection

Inflammatory bowel disease is caused by Viral hepatitis which generally affects by chronic hepatitis B virus with active disease and viral replication. In other case Hepatitis C virus affects the individual. This are mostly found in the rheumatic patients. Where the chron’s disease patients are at the high risk of HBV infection which may be due to the endoscopic and surgical procedure.

This Hepatitis B virus (HBV) can be divided into three broad categories such as active chronic, inactive carrier and resolved. Active HBV is generally denoted with the HBV DNA level more than or equal to 2000 UI per ml with the elevated alanine amino transfer whereas inactive HBV is defined by less than or equal to 2000 IU per ml and therefore the patients with immunosuppressive medication concern with the change in serum amino transfer as per the epidemiological and treatment group studies

This cumulative prevalence of either HCV or HBV seem to present a large variance with all patients with HBV infection should be treated when they have both increased liver enzymes and positive HBV-DNA.

If a patient administered corticosteroids or immunomodulators prophylactic HBV treatment should be initiated despite HBV-DNA and transaminase levels in this Pegylated and ribavirin acts as a first combination of choice for the initial stage of treatment as slowly the therapy varies according to the genotype and virologic response of the patient. During the treatment of HCV patients received antiviral therapy when compared to the infection by both hepatitis virus HCV causes high risk in patients as patient with HCV infection died of acute on chronic liver failure.

Session on infectious disease: goo.gl/9nxj3S